Director of Strategic Finance and Corporate Development, Lyra Health
$150-229k
+ Discretionary restricted stock units
Mental health employee benefits
Job no longer available
Mental health employee benefits
1001+ employees
Job no longer available
$150-229k
+ Discretionary restricted stock units
1001+ employees
Company mission
To transform access to life-changing mental health care.
Role
Who you are
- 8+ years work experience, with 2+ years of private equity direct investing experience (required)
- Advanced financial modeling skills with the ability to distill complex decisions into simple but comprehensive financial models
- Excellent organizational and time management skills, including the ability to prioritize and balance multiple deliverables with competing timelines in a dynamic environment
- Exceptional written and oral communication skills, with the ability to clearly convey recommendations and conclusions. Experience presenting thoughtful analysis and a compelling point of view directly to senior leadership
- Proven success developing and/or improving processes, with a desire to inspire change across the organization
- Ability to collect, organize and analyze complex data at a macro and micro level with minimal supervision. Actively seeks the input and opinions of stakeholders; explores and considers a wide range of options before acting
- Demonstrates high critical thinking and problem-solving skills and strong attention to detail as well as an ability to tackle ambiguous situations
- Must be a proactive self-starter with exceptional follow-through and the ability to work well independently with minor supervision
What the job involves
- Lyra is looking for a highly motivated Director of Strategic Finance & Corporate Development to help us realize our mission of becoming the premier mental health solution for employers and employees
- The role will be responsible for flexing across multiple lanes, including pricing strategy, new product development and M&A, and will be a key finance thought leader within Lyra
- Pricing strategy: partner with Go-To-Market to set pricing for new sales & renewals globally, balancing profitability targets and market dynamics to make high-quality pricing decisions
- New product development: partner with Go-To-Market and Ops teams to recommend pricing for new products & business lines that balances sustainability & market dynamics
- Unit economics thought leadership: propose and lead execution of analytics that help Lyra better understand key profitability levers, to inform pricing strategy and hurdle rates for new investment
- M&A strategy & execution: work closely with Lyra’s executive team to align on what types of M&A opportunities Lyra should consider, as well as a framework for when we should build/buy/partner. Lead deal execution, including business & financial due diligence, presenting recommendations to Lyra’s executive team and Board
Our take
In the US, millions of people suffer from mental illness each year. This is not only a detriment to individuals, but to businesses as well - with research suggesting that depression and anxiety disorders lead to $1 trillion in lost productivity worldwide each year.
Lyra Health is out to tackle these issues head-on, by delivering mental health care for employees. The company offers video counselling sessions and one-to-one messaging to help users with a variety of conditions including anxiety, depression and substance use disorder.
The company is a key player in the sector alongside peers like Calm, Genoa and Talkspace. Impressively, it boasts a 90% satisfaction rate across its more than 2 million members, demonstrating the impact its products can have.
In 2025, Lyra Health launched a ‘clinical-grade’ chatbot to its offering. This has been met with mixed feelings due to evidence that AI can act unpredictably in response to mental health concerns. It will take time to see whether this feature will enhance or diminish the user experience.
Freddie
Company Specialist at Welcome to the Jungle
Insights
40% employee growth in 12 months
Company
Funding (last 2 of 8 rounds)
Jan 2022
$35m
SERIES F
May 2021
$200m
SERIES F
Total funding: $690.1m
Company benefits
- Full access to Lyra’s mental health services for employees and their eligible dependents—at no charge
- Medical, dental, and vision benefits, and free monthly membership to One Medical
- 401k and equity options
- Four weeks of vacation and paid holidays
- Monthly tech stipend
Company HQ
Downtown, Burlingame, CA
Leadership
David Ebersman
(Co-Founder & Board Chair)Former CEO of the company. Was an Equity Research Analyst at Oppenheimer & Co. Also served as the CFO at Facebook, and worked at Genentech for 15 years, leaving as Chief Financial Officer & Executive VP.
Jennifer Schulz
(CEO)Former CEO of Experian North America, Head of Global Online and Digital Products at Visa, and CEO at Verifi.
Share this job
View 13 more jobs at Lyra Health